Gastric FTO and MC4R Expression in Sleeve Gastrectomy Patients: Limited Predictive Value for Weight Loss

Overview

This study investigated the expression of FTO and MC4R genes in gastric tissue of patients undergoing sleeve gastrectomy. While both genes are implicated in energy homeostasis and obesity, their gastric expression showed no predictive capacity for postoperative weight loss outcomes.

Background

Obesity is a complex, chronic disease influenced by genetic and environmental factors, with FTO and MC4R genes playing significant roles in energy regulation and appetite control. FTO is widely expressed and linked to increased energy intake and adiposity, whereas MC4R mediates anorexigenic signals primarily in the hypothalamus but is also expressed peripherally, including the gastrointestinal tract. Understanding the local expression of these genes in gastric tissue may provide insights into metabolic regulation and potential personalized obesity treatments.

Data Highlights

The study measured gastric expression levels of FTO and MC4R in patients undergoing sleeve gastrectomy. Despite known associations of these genes with obesity and energy balance, no significant correlation was found between their gastric expression and postoperative weight loss metrics. This suggests that gastric gene expression of FTO and MC4R lacks diagnostic relevance for predicting weight loss success after bariatric surgery.

Key Findings

• FTO and MC4R genes are expressed in human gastric tissue, consistent with prior evidence of peripheral expression beyond the CNS.
• Gastric expression levels of FTO and MC4R do not correlate with patients’ baseline BMI or metabolic status.
• No predictive relationship was observed between gastric FTO or MC4R expression and weight loss outcomes following sleeve gastrectomy.
• Genetic variants of FTO and MC4R influence systemic energy balance but may not impact local gastric gene expression relevant to weight loss.
• The gastrointestinal tract’s role in energy homeostasis involves complex signaling pathways that may not be directly reflected by gastric gene expression of these loci.

Clinical Implications

Assessment of gastric FTO and MC4R expression is unlikely to provide useful prognostic information for weight loss after sleeve gastrectomy. Clinicians should continue to rely on established clinical and metabolic parameters when evaluating bariatric surgery candidates. Future research may explore other molecular markers or systemic gene expression profiles for better predictive capacity.

Conclusion

Although FTO and MC4R are key regulators of energy balance, their expression in gastric tissue does not predict weight loss outcomes post-sleeve gastrectomy. This highlights the complexity of obesity genetics and the need for multifaceted approaches to personalized obesity management.

References

1. Obesity and Energy Dysregulation References [1-4]
2. FTO Gene Function and Expression Studies [7-14]
3. MC4R Gene Role and Genetic Variants [15-23]
4. Gastrointestinal Tract and Metabolic Regulation [24-27]
5. Genetic Variants and Weight Loss Associations [28-36]